Ascendis Pharma A/S Ordinary Share (ASND) is a publicly traded Healthcare sector company. As of October 10, 2026, ASND trades at $229.14 with a market cap of $14.65B and a P/E ratio of 0.00. ASND moved +2.97% today. Year to date, ASND is +7.47%; over the trailing twelve months it is +6.73%. Its 52-week range spans $124.06 to $282.15. Analyst consensus is strong buy with an average price target of $317.47. Rallies surfaces ASND's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Ascendis Pharma A/S Ordinary Share (ASND) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ASND moved +2.97% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $229.14 |
| Market Cap | $14.65B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $282.15 |
| 52-Week Low | $124.06 |
| Volume | 646.98K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
18 analysts cover ASND: 0 strong buy, 18 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $317.47.